NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/27/25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
   |
135 |
| 03/26/25 | 8-K | Current report |
|
|
7 |
| 03/24/25 | 8-K | Current report |
|
|
4 |
| 03/11/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/10/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/05/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/24/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/05/25 | 8-K | Current report filing |
|
|
20 |
| 11/29/24 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
7 | |
| 11/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
224 |